Dezheng Huo

[Sarah Shubeck MD MS @spshubeck]

Excited to share our latest from @UCCancerCenter -
Response to Treatment, Racial and Ethnic Disparity, and Survival in Patients With Breast Cancer Undergoing Neoadjuvant Chemotherapy in the US

@fredhow @folopade @UChicagoBreast

https://t.co/c7didsfFxo

[Fred Howard @fredhow]

We trained models to account for biases in TCGA https://t.co/H4W8iH23lA https://t.co/0BwkztJW8R - resulting in equal accuracy in training / validation in our diverse @UChicagoMed cohort. We also saw equal accuracy in Black patients - important for #healthequity in #technology

[JAMA Oncology @JAMAOnc]

In an analysis of over one million pts with #breastcancer, HER2-low status had minimal impact on breast cancer survival & chemotherapy response when compared to HER2-0 disease in an analysis prior to introduction of potent antibody-drug conjugates. https://t.co/Z4T9r6MzBU #BCSM